ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,035.69
      -1.57%
      US Tech 100
      16,926.80
      -2.21%
      Dow Jones
      37,815.92
      -1.49%
      Brent Oil
      85.57
      -0.38%
      Bitcoin
      60,236.06
      -0.60%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Bright Minds Biosciences Inc (DRUG)

      7. Bright Minds Biosciences Inc (DRUG) News

      DRUG

      Bright Minds Biosciences (DRUG)

      Bright Minds Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:DRUG
      DateTimeSourceHeadlineSymbolCompany
      12:53PMiHub NewswireFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      02/26/20248:18PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:DRUGBright Minds Biosciences Inc
      02/26/20248:10PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:DRUGBright Minds Biosciences Inc
      02/12/20249:56PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRUGBright Minds Biosciences Inc
      01/18/202412:57PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:DRUGBright Minds Biosciences Inc
      12/29/20234:30PMEdgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:DRUGBright Minds Biosciences Inc
      12/08/20236:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRUGBright Minds Biosciences Inc
      12/06/20235:08PMPR Newswire (Canada)Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by ManagementNASDAQ:DRUGBright Minds Biosciences Inc
      08/08/20234:24PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRUGBright Minds Biosciences Inc
      08/08/20236:50AMGlobeNewswire Inc.Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101NASDAQ:DRUGBright Minds Biosciences Inc
      07/20/20231:49PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRUGBright Minds Biosciences Inc
      07/20/20236:50AMGlobeNewswire Inc.Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101NASDAQ:DRUGBright Minds Biosciences Inc
      07/12/20234:55PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRUGBright Minds Biosciences Inc
      07/11/20236:50AMGlobeNewswire Inc.Bright Minds Announces Effective Date of Share ConsolidationNASDAQ:DRUGBright Minds Biosciences Inc
      06/22/20233:37PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:DRUGBright Minds Biosciences Inc
      06/22/20236:50AMGlobeNewswire Inc.Bright Minds Announces Proposed Share ConsolidationNASDAQ:DRUGBright Minds Biosciences Inc
      05/15/20235:26PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:DRUGBright Minds Biosciences Inc
      04/19/20236:50AMGlobeNewswire Inc.Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202NASDAQ:DRUGBright Minds Biosciences Inc
      04/10/20238:15AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:DRUGBright Minds Biosciences Inc
      04/10/20236:50AMGlobeNewswire Inc.Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin ResearchNASDAQ:DRUGBright Minds Biosciences Inc
      03/02/20232:38PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:DRUGBright Minds Biosciences Inc
      02/27/20236:50AMGlobeNewswire Inc.Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023NASDAQ:DRUGBright Minds Biosciences Inc
      02/17/20236:50AMGlobeNewswire Inc.Bright Minds Biosciences Announces Non-Executive Director AppointmentNASDAQ:DRUGBright Minds Biosciences Inc
      02/08/20235:25PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:DRUGBright Minds Biosciences Inc
      02/08/20234:05PMGlobeNewswire Inc.Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee RequirementsNASDAQ:DRUGBright Minds Biosciences Inc
      02/07/20235:16PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:DRUGBright Minds Biosciences Inc
      01/27/20234:05PMGlobeNewswire Inc.Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price DeficiencyNASDAQ:DRUGBright Minds Biosciences Inc
      01/09/20234:05PMGlobeNewswire Inc.Bright Minds Biosciences Announces Resignation of Board MemberNASDAQ:DRUGBright Minds Biosciences Inc
      12/06/20226:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:DRUGBright Minds Biosciences Inc
      12/02/20227:06PMGlobeNewswire Inc.Bright Minds Biosciences Announces Closing of Non-Brokered Private PlacementNASDAQ:DRUGBright Minds Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:DRUG